Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 9.9810.3813.946.777.94

What is the latest EV/Core EBITDA ratio of ANUH PHARMA ?

The latest EV/Core EBITDA ratio of ANUH PHARMA is 9.98 based on Mar2026 Standalone results.
Year EV/Core EBITDA
Mar20269.98
Mar202510.38
Mar202413.94
Mar20236.77
Mar20227.94

How is EV/Core EBITDA of ANUH PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 9.98
-3.85
Mar2025 10.38
-25.54
Mar2024 13.94
105.91
Mar2023 6.77
-14.74
Mar2022 7.94 -

Other Financial Ratios of ANUH PHARMA


Compare EV/Core EBITDA ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹830.5 Cr 1.1% -11.4% 3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

1.1%

-11.4%

3.5%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses